{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:27:23Z","timestamp":1786512443022,"version":"build-2736575974"},"reference-count":86,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science, Technological Development and Innovation","award":["451-03-33\/2026-03\/200161"],"award-info":[{"award-number":["451-03-33\/2026-03\/200161"]}]},{"name":"Ministry of Science, Technological Development and Innovation","award":["451-03-34\/2026-03\/200161"],"award-info":[{"award-number":["451-03-34\/2026-03\/200161"]}]},{"award":["451-03-33\/2026-03\/200161"],"award-info":[{"award-number":["451-03-33\/2026-03\/200161"]}],"id":[{"id":"https:\/\/ror.org\/01znas443","id-type":"ROR","asserted-by":"publisher"}]},{"award":["451-03-34\/2026-03\/200161"],"award-info":[{"award-number":["451-03-34\/2026-03\/200161"]}],"id":[{"id":"https:\/\/ror.org\/01znas443","id-type":"ROR","asserted-by":"publisher"}]},{"name":"University of Belgrade","award":["451-03-33\/2026-03\/200017"],"award-info":[{"award-number":["451-03-33\/2026-03\/200017"]}]},{"award":["451-03-33\/2026-03\/200017"],"award-info":[{"award-number":["451-03-33\/2026-03\/200017"]}],"id":[{"id":"https:\/\/ror.org\/02qsmb048","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Background: Phosphatidylinositol 3-kinase (PI3K) is a promising anticancer drug target, and selective PI3K\u03b1 inhibition may provide both efficacy and an improved safety profile. This study aimed to design new potentially selective PI3K\u03b1 inhibitors using computer-aided drug design (CADD). Methods: Benzoxazepine and thiazole derivatives were investigated using molecular dynamics, ensemble docking, and Three-Dimensional Quantitative Structure\u2013Activity Relationship (3D-QSAR) analyses. Scaffold hopping, substituent replacement, structure-based virtual screening, and density functional theory (DFT) calculations were then applied to guide the design and characterization of new derivatives. Results: The study identified new chemotypes capable of interacting with PI3K\u03b1 Val851 (\u03b1Val851) in the hinge region, including chromeno[3,4-d]imidazole, 2H-benzo[b]oxazine, and quinoline derivatives. Additional substructures directed toward hydrophobic region II and the \u03b1Gln859 interaction environment supported predicted selectivity over PI3K\u03b2, PI3K\u03b3, and PI3K\u03b4. Conclusions: The results establish a comprehensive CADD framework for the rational design of selective PI3K\u03b1 inhibitors and provide new compounds with improved predicted selectivity profiles for further development.<\/jats:p>","DOI":"10.3390\/molecules31162782","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:38:09Z","timestamp":1786361889000},"page":"2782","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Computational Framework for the Design and Development of Isoform Selective PI3K\u03b1 Inhibitors as Novel Anticancer Agents"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-443X","authenticated-orcid":false,"given":"Milan","family":"Jovanovi\u0107","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia"},{"name":"Department of Molecular Biology and Endocrinology, \u201cVINCA\u201d Institute of Nuclear Sciences\u2014National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12\u201314, Vinca, 11351 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Djikic-Stojsic","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-9005","authenticated-orcid":false,"given":"Branislav","family":"Stankovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Nuclear and Plasma Physics, \u201cVINCA\u201d Institute of Nuclear Sciences\u2014National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12\u201314, Vinca, 11351 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-3211","authenticated-orcid":false,"given":"Marija","family":"Popovic-Nikolic","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3656-9245","authenticated-orcid":false,"given":"Katarina","family":"Nikolic","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in Cancer: Divergent Roles of Isoforms, Modes of Activation and Therapeutic Targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting the PI3K Pathway in Cancer: Are We Making Headway?","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.18632\/oncotarget.12742","article-title":"Recent Development of ATP-Competitive Small Molecule Phosphatidylinostitol-3-Kinase Inhibitors as Anticancer Agents","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and Cancer: Lessons, Challenges and Opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ctrv.2017.07.005","article-title":"Phosphoinositide 3-Kinase (PI3K) Pathway Inhibitors in Solid Tumors: From Laboratory to Patients","volume":"59","author":"Janku","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/aps.2015.71","article-title":"PI3K Isoform-Selective Inhibitors: Next-Generation Targeted Cancer Therapies","volume":"36","author":"Wang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0065-230X(09)02002-8","article-title":"PI3K\/PTEN Signaling in Angiogenesis and Tumorigenesis","volume":"102","author":"Jiang","year":"2009","journal-title":"Adv. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K\u2013AKT Network at the Interface of Oncogenic Signalling and Cancer Metabolism","volume":"20","author":"Hoxhaj","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.18632\/oncotarget.188","article-title":"Targeting the PI3K\/Akt\/MTOR Pathway\u2014Beyond Rapalogs","volume":"1","author":"Markman","year":"2010","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1126\/science.1150799","article-title":"The Structure of a Human p110\u03b1\/p85\u03b1 Complex Elucidates the Effects of Oncogenic PI3K\u03b1 Mutations","volume":"318","author":"Huang","year":"2007","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbapap.2009.11.020","article-title":"Somatic Mutations in PI3K\u03b1: Structural Basis for Enzyme Activation and Drug Design","volume":"1804","author":"Gabelli","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Proteins Proteom."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Miller, M.S., Thompson, P.E., and Gabelli, S.B. (2019). Structural Determinants of Isoform Selectivity in PI3K Inhibitors. Biomolecules, 9.","DOI":"10.3390\/biom9030082"},{"key":"ref_13","first-page":"768","article-title":"Alpelisib: A Novel Therapy for Patients with PIK3CA-Mutated Metastatic Breast Cancer","volume":"11","author":"Wilhoit","year":"2020","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt Signal Transduction for Cancer Therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast Cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.annonc.2020.10.596","article-title":"Phase III Randomized Study of Taselisib or Placebo with Fulvestrant in Estrogen Receptor-Positive, PIK3CA-Mutant, HER2-Negative, Advanced Breast Cancer: The SANDPIPER Trial","volume":"32","author":"Dent","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-024-02136-y","article-title":"Inavolisib: First Approval","volume":"85","author":"Blair","year":"2025","journal-title":"Drugs"},{"key":"ref_18","first-page":"120","article-title":"Inavolisib: A Selective Inhibitor of Mutant PI3K\u03b1 for the Treatment of Breast Cancer","volume":"3","author":"De","year":"2025","journal-title":"Oncol. Adv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s43018-021-00218-4","article-title":"The Present and Future of PI3K Inhibitors for Cancer Therapy","volume":"2","author":"Castel","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00204-023-03440-4","article-title":"Development and Safety of PI3K Inhibitors in Cancer","volume":"97","author":"Yu","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41598-024-83030-1","article-title":"Exploring Target Selectivity in Designing and Identifying PI3K\u03b1 Inhibitors for Triple Negative Breast Cancer with Fragment-Based and Bioisosteric Replacement Approach","volume":"15","author":"Halder","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.36922\/itps.2340","article-title":"Rational Drug Design from Phosphatidylinositol 3-Kinase-\u03b1 Inhibitors Through Molecular Docking and 3D-QSAR Methodologies for Cancer Immunotherapy","volume":"7","author":"Dibia","year":"2024","journal-title":"INNOSC Theranostics Pharmacol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1007\/s42250-025-01398-7","article-title":"Design of Novel PI3K\u03b1 Inhibitors by Combining 3D-QSAR, ADMET Screening, Molecular Docking, and Molecular Dynamics Simulations","volume":"8","author":"Wang","year":"2025","journal-title":"Chem. Afr."},{"key":"ref_24","first-page":"139","article-title":"Computer-Aided Drug Design: An Innovative Tool for Modeling","volume":"2","author":"Kore","year":"2012","journal-title":"Open J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3762\/bjoc.12.267","article-title":"Computational Methods in Drug Discovery","volume":"12","author":"Leelananda","year":"2016","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1021\/acs.jmedchem.5b01483","article-title":"The Rational Design of Selective Benzoxazepin Inhibitors of the \u03b1-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-Triazol-5-Yl)-5,6-Dihydrobenzo[f]Imidazo [1,2-d][1,4]Oxazepin-9-Yl)Oxy)Propanamide (GDC-0326)","volume":"59","author":"Heffron","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1016\/j.bmcl.2012.07.042","article-title":"Development of Isoform Selective PI3-Kinase Inhibitors as Pharmacological Tools for Elucidating the PI3K Pathway","volume":"22","author":"Bruce","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1196\/annals.1292.017","article-title":"The Appropriateness of Density-Functional Theory for the Calculation of Molecular Electronics Properties","volume":"1006","author":"Reimers","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/jacsau.2c00085","article-title":"Describing Chemical Reactivity with Frontier Molecular Orbitalets","volume":"2","author":"Yu","year":"2022","journal-title":"JACS Au"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e1601","DOI":"10.1002\/wcms.1601","article-title":"Molecular Electrostatic Potential Analysis: A Powerful Tool to Interpret and Predict Chemical Reactivity","volume":"12","author":"Suresh","year":"2022","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1021\/jp0225774","article-title":"Ionization Potential, Electron Affinity, Electronegativity, Hardness, and Electron Excitation Energy: Molecular Properties from Density Functional Theory Orbital Energies","volume":"107","author":"Zhan","year":"2003","journal-title":"J. Phys. Chem. A"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jcc.26886","article-title":"Electrophilicity Index Revisited","volume":"44","author":"Pal","year":"2023","journal-title":"J. Comput. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4155\/fmc-2023-0390","article-title":"Application of Parallel Artificial Membrane Permeability Assay Technique and Chemometric Modeling for Blood\u2013Brain Barrier Permeability Prediction of Protein Kinase Inhibitors","volume":"16","author":"Radan","year":"2024","journal-title":"Future Med. Chem."},{"key":"ref_34","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Mennucci, B., and Petersson, G.A. (Gaussian 09, 2009). Gaussian 09, Revision A.02."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Webb, B., and Sali, A. (2016). Comparative Protein Structure Modeling Using MODELLER. Curr. Protoc. Bioinform., 54.","DOI":"10.1002\/cpbi.3"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A Visualization System for Exploratory Research and Analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and Validation of a Genetic Algorithm for Flexible Docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: A Web-Based Graphical User Interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: An Improved Force Field for Folded and Intrinsically Disordered Proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM General Force Field: A Force Field for Drug-like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"044130","DOI":"10.1063\/5.0014475","article-title":"Scalable Molecular Dynamics on CPU and GPU Architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/protein\/9.11.1063","article-title":"An Automated Approach for Clustering an Ensemble of NMR-Derived Protein Structures into Conformationally Related Subfamilies","volume":"9","author":"Kelley","year":"1996","journal-title":"Protein Eng."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/bioinformatics\/btw215","article-title":"CaFE: A Tool for Binding Affinity Prediction Using End-Point Free Energy Methods","volume":"32","author":"Liu","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pro.3280","article-title":"Improvements to the APBS Biomolecular Solvation Software Suite","volume":"27","author":"Jurrus","year":"2018","journal-title":"Protein Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA Methods to Estimate Ligand-Binding Affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_47","unstructured":"(BIOVIA Discovery Studio Visualizer, 2024). BIOVIA Discovery Studio Visualizer, version 2024."},{"key":"ref_48","unstructured":"(Pentacle, 2009). Pentacle, version 1.07."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1021\/jm000941m","article-title":"GRid-INdependent Descriptors (GRIND): A Novel Class of Alignment-Independent Three-Dimensional Molecular Descriptors","volume":"43","author":"Pastor","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Cruciani, G. (2006). Calculation and Application of Molecular Interaction Fields. Molecular Interaction Fields: Applications in Drug Discovery and ADME Prediction, Wiley-VCH.","DOI":"10.1002\/3527607676"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/ci800037t","article-title":"Development and Validation of AMANDA, a New Algorithm for Selecting Highly Relevant Regions in Molecular Interaction Fields","volume":"48","author":"Pastor","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"ref_52","unstructured":"Dur\u00e1n Alcaide, \u00c1. (2011). Development of High-Performance Algorithms for a New Generation of Versatile Molecular Descriptors: The Pentacle Software. [Ph.D. Dissertation, Universitat Pompeu Fabra]."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/qsar.19930120103","article-title":"Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D-QSAR Problems","volume":"12","author":"Baroni","year":"1993","journal-title":"Quant. Struct.-Act. Relatsh."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chemolab.2011.08.007","article-title":"Comparative QSARs for Antimalarial Endochins: Importance of Descriptor-Thinning and Noise Reduction Prior to Feature Selection","volume":"109","author":"Ojha","year":"2011","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best Practices for QSAR Model Development, Validation, and Exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol. Inform."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.chemolab.2011.03.011","article-title":"Further Exploring Rm2 Metrics for Validation of QSPR Models","volume":"107","author":"Ojha","year":"2011","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/ci200520g","article-title":"Comparative Studies on Some Metrics for External Validation of QSPR Models","volume":"52","author":"Roy","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1021\/ci200211n","article-title":"Real External Predictivity of QSAR Models: How to Evaluate It? Comparison of Different Validation Criteria and Proposal of Using the Concordance Correlation Coefficient","volume":"51","author":"Chirico","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_59","unstructured":"OECD (2014). Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models, OECD Publishing."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Roy, K., Kar, S., and Das, R.N. (2015). A Primer on QSAR\/QSPR Modeling, Springer.","DOI":"10.1007\/978-3-319-17281-1"},{"key":"ref_61","unstructured":"(PASW Statistics for Windows, 2009). PASW Statistics for Windows, version 18.0."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Brown, N. (2013). Scaffold Diversity in Medicinal Chemistry Space. Scaffold Hopping in Medicinal Chemistry, Wiley-VCH.","DOI":"10.1002\/9783527665143"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/ci050357s","article-title":"Molecular Field Extreme as Descriptors of Biological Activity: Definition and Validation","volume":"46","author":"Cheeseright","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Brown, N. (2013). The XED Force Field and Spark. Scaffold Hopping in Medicinal Chemistry, Wiley-VCH.","DOI":"10.1002\/9783527665143"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional Thermochemistry. III. The Role of Exact Exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00894-016-3175-x","article-title":"Evaluating Frontier Orbital Energy and HOMO\/LUMO Gap with Descriptors from Density Functional Reactivity Theory","volume":"23","author":"Huang","year":"2017","journal-title":"J. Mol. Model."},{"key":"ref_67","unstructured":"(Chem3D Ultra, 2002). Chem3D Ultra, version 7.0."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/elps.201200171","article-title":"Quantitative Structure-Mobility Relationship Analysis of Imidazoline Receptor Ligands in CDs-Mediated CE","volume":"34","author":"Filipic","year":"2013","journal-title":"Electrophoresis"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: A Multifunctional Wavefunction Analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"082503","DOI":"10.1063\/5.0216272","article-title":"A Comprehensive Electron Wavefunction Analysis Toolbox for Chemists, Multiwfn","volume":"161","author":"Lu","year":"2024","journal-title":"J. Chem. Phys."},{"key":"ref_71","unstructured":"(2026, August 04). Jmol: An Open-Source Java Viewer for Chemical Structures in 3D. Jmol Development Team. Available online: https:\/\/jmol.sourceforge.net\/."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/ci600253e","article-title":"A Common Reference Framework for Analyzing\/Comparing Proteins and Ligands. Fingerprints for Ligands and Proteins (FLAP): Theory and Application","volume":"47","author":"Baroni","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ci300153d","article-title":"GRID-Based Three-Dimensional Pharmacophores I: FLAPpharm, a Novel Approach for Pharmacophore Elucidation","volume":"52","author":"Cross","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jcim.6b00122","article-title":"Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way Toward Selective Promiscuity by Design?","volume":"56","author":"Papadatos","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/ml1001932","article-title":"Synthesis and In Vitro and In Vivo Evaluation of Phosphoinositide-3-Kinase Inhibitors","volume":"2","author":"Burger","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An Open Chemical Toolbox","volume":"3","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/minf.201200133","article-title":"Ambit-Tautomer: An Open Source Tool for Tautomer Generation","volume":"32","author":"Kochev","year":"2013","journal-title":"Mol. Inform."},{"key":"ref_78","unstructured":"Berthold, M.R., Cebron, N., Dill, F., Di Fatta, G., Gabriel, T.R., Georg, F., Meinl, T., Ohl, P., Sieb, C., and Wiswedel, B. (2006, January 5\u20137). KNIME: The Konstanz Information Miner. Proceedings of the 4th International Industrial Simulation Conference (ISC 2006), Palermo, Italy."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acs.jcim.0c00598","article-title":"Property-Unmatched Decoys in Docking Benchmarks","volume":"61","author":"Stein","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1021\/acs.jcim.5b00169","article-title":"A Pipeline to Enhance Ligand Virtual Screening: Integrating Molecular Dynamics and Fingerprints for Ligand and Proteins","volume":"55","author":"Spyrakis","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_81","unstructured":"(ADMET Predictor, 2024). ADMET Predictor, version 12.0."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kaski, S. (2011). Self-Organizing Maps. Encyclopedia of Machine Learning, Springer.","DOI":"10.1007\/978-0-387-30164-8_746"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1752-153X-6-S2-S1","article-title":"Self Organising Maps for Visualising and Modelling","volume":"6","author":"Brereton","year":"2012","journal-title":"Chem. Cent. J."},{"key":"ref_85","unstructured":"Landrum, G. (2026, August 04). RDKit: Open-Source Cheminformatics. Available online: https:\/\/www.rdkit.org\/."},{"key":"ref_86","unstructured":"Vettigli, G. (2026, August 04). MiniSom: Minimalistic and NumPy-Based Implementation of the Self-Organizing Map. Available online: https:\/\/github.com\/JustGlowing\/minisom."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/16\/2782\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:33:40Z","timestamp":1786509220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/16\/2782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":86,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["molecules31162782"],"URL":"https:\/\/doi.org\/10.3390\/molecules31162782","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2025-5kh41-v2","asserted-by":"object"}]},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}